Programmed Death Ligand 1 (PD-L1) Expression in Epithelial Ovarian Cancer: A Comparison of Type I and Type II Tumors

OBJECTIVE: To examine the expression of programmed death ligand 1 (PD-L1) in type I and type II epithelial ovarian cancers (EOC) and its associations with outcomes. METHODS: Records of 132 women with EOC were reviewed. Immunostaining of PD-L1 was performed with formalin-fixed, paraffin-embedded spec...

Descripción completa

Detalles Bibliográficos
Autores principales: Nhokaew, Wilasinee, Kleebkaow, Pilaiwan, Chaisuriya, Nipon, Kietpeerakool, Chumnan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948887/
https://www.ncbi.nlm.nih.gov/pubmed/31030490
http://dx.doi.org/10.31557/APJCP.2019.20.4.1161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948887/
https://www.ncbi.nlm.nih.gov/pubmed/31030490
http://dx.doi.org/10.31557/APJCP.2019.20.4.1161

Ejemplares similares